ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $42,000 | -89.2% | 11,315 | -91.6% | 0.02% | -86.0% |
| Q4 2017 | $390,000 | -25.7% | 135,445 | +15.8% | 0.18% | -28.8% |
| Q3 2017 | $525,000 | -1.9% | 116,945 | +0.3% | 0.25% | -8.1% |
| Q2 2017 | $535,000 | +400.0% | 116,630 | +358.6% | 0.27% | +369.0% |
| Q1 2017 | $107,000 | +15.1% | 25,430 | +13.4% | 0.06% | +16.0% |
| Q4 2016 | $93,000 | -4.1% | 22,430 | +88.0% | 0.05% | -3.8% |
| Q3 2016 | $97,000 | – | 11,930 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |